Cargando…

Molecular Elucidation of Riboflavin Production and Regulation in Candida albicans, toward a Novel Antifungal Drug Target

Candida albicans is a major cause of fungal infections, both superficial and invasive. The economic costs as well as consequences for patient welfare are substantial. Only a few treatment options are available due to the high resemblance between fungal targets and host molecules, as both are eukaryo...

Descripción completa

Detalles Bibliográficos
Autores principales: Demuyser, Liesbeth, Palmans, Ilse, Vandecruys, Paul, Van Dijck, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7407072/
https://www.ncbi.nlm.nih.gov/pubmed/32759338
http://dx.doi.org/10.1128/mSphere.00714-20
_version_ 1783567541131542528
author Demuyser, Liesbeth
Palmans, Ilse
Vandecruys, Paul
Van Dijck, Patrick
author_facet Demuyser, Liesbeth
Palmans, Ilse
Vandecruys, Paul
Van Dijck, Patrick
author_sort Demuyser, Liesbeth
collection PubMed
description Candida albicans is a major cause of fungal infections, both superficial and invasive. The economic costs as well as consequences for patient welfare are substantial. Only a few treatment options are available due to the high resemblance between fungal targets and host molecules, as both are eukaryotes. Riboflavin is a yellow pigment, also termed vitamin B(2). Unlike animals, fungi can synthesize this essential component themselves, thereby leading us to appreciate that targeting riboflavin production is a promising novel strategy against fungal infections. Here, we report that the GTP cyclohydrolase encoded by C. albicans RIB1 (CaRIB1) is essential and rate-limiting for production of riboflavin in the fungal pathogen. We confirm the high potential of CaRib1 as an antifungal drug target, as its deletion completely impairs in vivo infectibility by C. albicans in model systems. Furthermore, the stimulating effect of iron deprivation and PKA activation on riboflavin production seems to involve CaRib1 and the upstream transcription factor CaSef1. Gathering insights in the synthesis mechanism of riboflavin in pathogenic fungi, like C. albicans, will allow us to design a novel strategy and specifically target this process to combat fungal infections. IMPORTANCE Candida albicans is an important fungal pathogen causing common superficial infections as well as invasive diseases with an extremely high morbidity and mortality. Antifungal therapies are limited in efficiency and availability. In this research, we describe the regulation of riboflavin production in C. albicans. Since riboflavin biosynthesis is essential to this organism, we can appreciate that targeting it would be a promising new strategy to combat these fungal infections. We provide evidence that one particular enzyme in the production process, CaRib1, would be most promising as an antifungal drug target, as it plays a central role in regulation and proves to be essential in a mouse model of systemic infection.
format Online
Article
Text
id pubmed-7407072
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher American Society for Microbiology
record_format MEDLINE/PubMed
spelling pubmed-74070722020-08-11 Molecular Elucidation of Riboflavin Production and Regulation in Candida albicans, toward a Novel Antifungal Drug Target Demuyser, Liesbeth Palmans, Ilse Vandecruys, Paul Van Dijck, Patrick mSphere Research Article Candida albicans is a major cause of fungal infections, both superficial and invasive. The economic costs as well as consequences for patient welfare are substantial. Only a few treatment options are available due to the high resemblance between fungal targets and host molecules, as both are eukaryotes. Riboflavin is a yellow pigment, also termed vitamin B(2). Unlike animals, fungi can synthesize this essential component themselves, thereby leading us to appreciate that targeting riboflavin production is a promising novel strategy against fungal infections. Here, we report that the GTP cyclohydrolase encoded by C. albicans RIB1 (CaRIB1) is essential and rate-limiting for production of riboflavin in the fungal pathogen. We confirm the high potential of CaRib1 as an antifungal drug target, as its deletion completely impairs in vivo infectibility by C. albicans in model systems. Furthermore, the stimulating effect of iron deprivation and PKA activation on riboflavin production seems to involve CaRib1 and the upstream transcription factor CaSef1. Gathering insights in the synthesis mechanism of riboflavin in pathogenic fungi, like C. albicans, will allow us to design a novel strategy and specifically target this process to combat fungal infections. IMPORTANCE Candida albicans is an important fungal pathogen causing common superficial infections as well as invasive diseases with an extremely high morbidity and mortality. Antifungal therapies are limited in efficiency and availability. In this research, we describe the regulation of riboflavin production in C. albicans. Since riboflavin biosynthesis is essential to this organism, we can appreciate that targeting it would be a promising new strategy to combat these fungal infections. We provide evidence that one particular enzyme in the production process, CaRib1, would be most promising as an antifungal drug target, as it plays a central role in regulation and proves to be essential in a mouse model of systemic infection. American Society for Microbiology 2020-08-05 /pmc/articles/PMC7407072/ /pubmed/32759338 http://dx.doi.org/10.1128/mSphere.00714-20 Text en Copyright © 2020 Demuyser et al. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Article
Demuyser, Liesbeth
Palmans, Ilse
Vandecruys, Paul
Van Dijck, Patrick
Molecular Elucidation of Riboflavin Production and Regulation in Candida albicans, toward a Novel Antifungal Drug Target
title Molecular Elucidation of Riboflavin Production and Regulation in Candida albicans, toward a Novel Antifungal Drug Target
title_full Molecular Elucidation of Riboflavin Production and Regulation in Candida albicans, toward a Novel Antifungal Drug Target
title_fullStr Molecular Elucidation of Riboflavin Production and Regulation in Candida albicans, toward a Novel Antifungal Drug Target
title_full_unstemmed Molecular Elucidation of Riboflavin Production and Regulation in Candida albicans, toward a Novel Antifungal Drug Target
title_short Molecular Elucidation of Riboflavin Production and Regulation in Candida albicans, toward a Novel Antifungal Drug Target
title_sort molecular elucidation of riboflavin production and regulation in candida albicans, toward a novel antifungal drug target
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7407072/
https://www.ncbi.nlm.nih.gov/pubmed/32759338
http://dx.doi.org/10.1128/mSphere.00714-20
work_keys_str_mv AT demuyserliesbeth molecularelucidationofriboflavinproductionandregulationincandidaalbicanstowardanovelantifungaldrugtarget
AT palmansilse molecularelucidationofriboflavinproductionandregulationincandidaalbicanstowardanovelantifungaldrugtarget
AT vandecruyspaul molecularelucidationofriboflavinproductionandregulationincandidaalbicanstowardanovelantifungaldrugtarget
AT vandijckpatrick molecularelucidationofriboflavinproductionandregulationincandidaalbicanstowardanovelantifungaldrugtarget